J&J to acquire Firefly Bio for $1 billion
In an effort to increase the number of oncology medications in its portfolio, Johnson & Johnson (J&J) said on Monday...
cancer treatment
Bristol Myers to pay $1.5 billion dollars, upfront, in conjunction with BioNTech for cancer medicine
In a deal that could be worth over 11 billion dollars for the German company, Bristol Myers Squibb announced Monday...
